Testimonials

Background stories of how others approached and experienced their European Horizon funding trajectory.

Health
Research Organisation

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.

Read the full article for details 

Published on • 1 year ago

Back to all testimonials

Related testimonials

These testimonials share at least one programme or target audience.

Health
University of Applied Sciences

iCARE4CVD: Thomas More participates in research on improving patient care

Funded under Horizon Europe’s Innovative Health Initiative (HORIZON-JU-IHI-2022-02-01) and running from 2023 to 2028, the iCARE4CVD project aims to improve patient care across the board, starting from those at risk of developing cardiovascular disease to those with advanced heart failure. Thomas More University of Applied Sciences plays an important role in the project focusing data analysis and AI modeling as well as on the implementation of Patient-Reported Outcome Measures and Patient-Reported Experience Measures. Find out more in the full article.
Read more
ERC
University Research Organisation

VIB, KU Leuven and Muna Therapeutics in CELLPHASE_AD: Researchers identify a key biological tipping point in Alzheimer’s disease

Read at original location
Digital, Industry & Space
Research Organisation

Prospects 5.0: Flanders Make coordinates research on the adoptation of Industry 5.0 principles

Flanders Make coordinates Horizon Europe Cluster 4 project PROSPECTS 5.0 which analyses how Industry 5.0 principles are being adopted across 14 real‑world industrial use cases in multiple sectors and countries. The consortium partners, among which also KU Leuven, UGent and Flemish SME OCTAVE, translate the gained insights into practical guidance and policy-relevant outputs.  
Read more
Health
Not for Profit

Theresa PCP: ZAS participates in research developing an on-site system to decontaminate hospital wastewater

Funded under Horizon Europe (HORIZON-HLTH-2024-CARE-14-01), running from 2025 to 2029, the THERESA PCP aims to launch a pre-commercial procurement process (PCP) based on the development of an environmentally sustainable on-site system to decontaminate hospital wastewater. Ziekenhuis aan de Stroom (ZAS) plays an important role in the project by contributing real-world insights from a large and diverse hospital network. Read more about the project in this testimonial.
Read more
Digital, Industry & Space Advanced Digital Skills
University Research Organisation

EU-funded projects advancing connectivity and digital innovation (KU Leuven, FARI (VUB/ULB) and imec)

Read at original location
Agro-Food, Environment
Research Organisation

PREMIERE: ILVO participates in research strengthening the multi-actor approach

Funded under Horizon Europe (HORIZON-CL6-2022-GOVERNANCE-01-14), running from 2023 to 2027, PREMIERE aims to strengthen the multi-actor approach by supporting the development of more relevant, coherent, and well-prepared project proposals. Flanders Research Institute for Agriculture, Fisheries and Food (EV ILVO) is partner in the project consortium and leads the work package on the development and dissemination of practical tools to help stakeholders prepare successful multi-actor proposals. Read more about the project in this testimonial.
Read more

Testimonial

image of iCARE4CVD: Thomas More participates in research on improving patient care

iCARE4CVD: Thomas More participates in research on improving patient care

Funded under Horizon Europe’s Innovative Health Initiative (HORIZON-JU-IHI-2022-02-01) and running from 2023 to 2028, the iCARE4CVD project aims to improve patient care across the board, starting from those at risk of developing cardiovascular disease to those with advanced heart failure. Thomas More University of Applied Sciences plays an important role in the project focusing data analysis and AI modeling as well as on the implementation of Patient-Reported Outcome Measures and Patient-Reported Experience Measures. Find out more in the full article.

Read the full article Check out the other testimonials 
Logo of VLAIO
Logo of FWO

NCP Flanders

Updates

Our Services

Legal mentions

Privacy Policy
Cookies

LinkedIn